When to consider targeted therapies in thrombotic microangiopathies in the modern era: walking the tightrope between cost, safety, and efficacy

Catherine R. Murphree, Sven R. Olson, Thomas G. DeLoughery, Joseph J. Shatzel

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'When to consider targeted therapies in thrombotic microangiopathies in the modern era: walking the tightrope between cost, safety, and efficacy'. Together they form a unique fingerprint.

Medicine & Life Sciences